{"id":"73823d83-172b-4f1f-9730-e739c322d9cd","modelId":"c156c3ce-ec4e-496e-aeef-28a6a9af4e77","versionId":null,"locationId":"63e09f85-2dc7-4e87-a172-6f58dcb3673a","operatorId":null,"ownerId":null,"slug":"endoquest-els-boston-massachusetts-usa","status":"pilot","firstSeen":"2022-08-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.prnewswire.com/news-releases/endoquest-robotics-announces-installation-of-the-first-endoluminal-surgical-system-to-advance-the-clinical-and-procedural-development-of-the-els-system-at-brigham-and-womens-hospital-in-boston-massachusetts-301615110.html","name":"PR Newswire","title":"EndoQuest Robotics Announces Installation of the First Endoluminal Surgical System at Brigham and Women's Hospital"}],"notes":"EndoQuest announced installation of the first ELS System at Brigham and Women's Hospital in August 2022. BWH designated as first Center of Excellence and training facility, and center for planned IDE clinical study (PARADIGM trial).","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-08T22:32:46.726Z","updatedAt":"2026-08-09T04:18:49.811Z","model":{"id":"c156c3ce-ec4e-496e-aeef-28a6a9af4e77","companyId":"06e82f4d-e2d5-4a09-a089-c752f2f22056","modelName":"Endoluminal Surgical (ELS) System","slug":"endoquest-els","description":"Endoluminal Surgical (ELS) System is a surgical robot from EndoQuest Robotics, currently in pilot deployment.","formFactor":"surgical","industryVertical":null,"environment":null,"maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.massdevice.com/endoquest-gets-fda-green-light-to-initiate-final-stage-of-surgical-robot-trial/","title":"EndoQuest FDA green light PARADIGM","sourceName":"MassDevice","dateAccessed":"2026-07-22"},{"url":"https://finance.yahoo.com/news/endoquest-robotics-secures-series-d-120000732.html","title":"EndoQuest Series D-2 Funding","sourceName":"Yahoo Finance/GlobeNewswire","dateAccessed":"2026-07-22"},{"url":"https://www.businesswire.com/news/home/20260112765182/en/EndoQuest-to-Bring-AI-Powered-Vision-and-Precision-to-Endoluminal-Robotic-Surgery-with-NVIDIA-IGX-Thor","title":"EndoQuest NVIDIA IGX Thor","sourceName":"BusinessWire","dateAccessed":"2026-07-22"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Manufacturer","value":"EndoQuest Robotics"},{"label":"Type","value":"Surgical robot"},{"label":"Maturity","value":"Pilot deployment"}],"createdAt":"2026-07-22T23:21:51.831Z","updatedAt":"2026-08-09T03:57:34.330Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"06e82f4d-e2d5-4a09-a089-c752f2f22056","name":"EndoQuest Robotics","slug":"endoquest","description":"Houston-based endoluminal robotic surgery company. CEO Eduardo Fonseca. Endoluminal Surgical (ELS) System — flexible robot for scar-free procedures through natural orifices. PARADIGM Trial: FDA-approved final stage (Jan 2026), 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA). First robotic ESD by gastroenterologist in IDE trial (Oct 2025). Series D-2 co-led by Crescent Enterprises + Dr. Fred Moll (Intuitive Surgical co-founder). NVIDIA IGX Thor integration for AI vision. $176M total raised.","status":null,"founded":null,"hq":"Houston, TX","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-05T14:28:12.044Z","hqAddress":null,"hqPrecision":null,"website":"endoquestrobotics.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.massdevice.com/endoquest-gets-fda-green-light-to-initiate-final-stage-of-surgical-robot-trial/","title":"EndoQuest FDA green light PARADIGM","sourceName":"MassDevice","dateAccessed":"2026-07-22"},{"url":"https://finance.yahoo.com/news/endoquest-robotics-secures-series-d-120000732.html","title":"EndoQuest Series D-2 Funding","sourceName":"Yahoo Finance/GlobeNewswire","dateAccessed":"2026-07-22"},{"url":"https://www.businesswire.com/news/home/20260112765182/en/EndoQuest-to-Bring-AI-Powered-Vision-and-Precision-to-Endoluminal-Robotic-Surgery-with-NVIDIA-IGX-Thor","title":"EndoQuest NVIDIA IGX Thor","sourceName":"BusinessWire","dateAccessed":"2026-07-22"}],"keyFacts":[{"label":"Product","value":"Endoluminal Surgical (ELS) System — flexible endoluminal robot"},{"label":"Trial","value":"PARADIGM — FDA IDE, 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA)"},{"label":"FDA Status","value":"Final stage approved (Jan 2026). First robotic ESD by gastroenterologist (Oct 2025)."},{"label":"Total Funding","value":"$176M (Series D-2, Crescent Enterprises + Dr. Fred Moll co-led)"},{"label":"Partnership","value":"NVIDIA IGX Thor integration for AI-powered vision"},{"label":"CEO","value":"Eduardo Fonseca"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-22T21:32:37.672Z","updatedAt":"2026-08-05T14:39:59.309Z"}},"version":null,"location":{"id":"63e09f85-2dc7-4e87-a172-6f58dcb3673a","name":"Boston, Massachusetts, USA","slug":"boston-massachusetts-usa","kind":"city","parentLocationId":null,"region":null,"lat":42.3588336,"lng":-71.0578303,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":"Coordinates auto-geocoded on create via OpenStreetMap Nominatim (unverified; confirm before relying on map placement).","createdAt":"2026-08-08T20:16:29.044Z","updatedAt":"2026-08-09T04:26:19.821Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/endoquest-els-boston-massachusetts-usa","url":"https://registry.deploy.report/deployments/endoquest-els-boston-massachusetts-usa","name":"Endoluminal Surgical (ELS) System at Boston, Massachusetts, USA","identifier":"73823d83-172b-4f1f-9730-e739c322d9cd","startDate":"2022-08-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/boston-massachusetts-usa","name":"Boston, Massachusetts, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/endoquest","name":"EndoQuest Robotics"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/endoquest-els","name":"Endoluminal Surgical (ELS) System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}